NAPQI, a metabolite of Acetaminophen, causes negative interference with the recalled product assays at levels present in the serum/plasma of overdose patients.
Source facts
Action
The recalling firm issued letters dated 8/21/2018 via email or postal mail if an email address was not available on 8/24/2018 to their customers. The letter identified the affected product, problem and actions to be taken. For questions call 1-800-223-0139 in the United States and Canada. Outside the United States and Canada contact local Beckman Coulter Representative.
Initiated
2018-08-24
Root cause
Nonconforming Material/Component
Terminated
2024-08-02
Distribution
Distribution was nationwide. There was government and military distribution. Foreign distribution was made to Canada.
Recall number
Z-0210-2020
Recall status
Terminated
CDRH record ID
175792
FDA record created
2019-10-24
Recall event number
83583
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.